200,000+ products from a single source!

sales@angenechem.com

Home > Sulfanilamide > 64984-09-4

64984-09-4

64984-09-4 | 2-phenylethene-1-sulfonamide

CAS No: 64984-09-4 Catalog No: AG019M4X MDL No:MFCD00118353

Product Description

Catalog Number:
AG019M4X
Chemical Name:
2-phenylethene-1-sulfonamide
CAS Number:
64984-09-4
Molecular Formula:
C8H9NO2S
Molecular Weight:
183.2276
MDL Number:
MFCD00118353
IUPAC Name:
2-phenylethenesulfonamide
InChI:
InChI=1S/C8H9NO2S/c9-12(10,11)7-6-8-4-2-1-3-5-8/h1-7H,(H2,9,10,11)
InChI Key:
SHPHBMZZXHFXDF-UHFFFAOYSA-N
SMILES:
NS(=O)(=O)C=Cc1ccccc1

Properties

Complexity:
245  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
183.035g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
183.225g/mol
Monoisotopic Mass:
183.035g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
68.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
1  
XLogP3:
0.9  

Literature

Title Journal
Interaction of the ARF tumor suppressor with cytosolic HSP70 contributes to its autophagy function. Cancer biology & therapy 20110915
HSP70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells. Molecular cancer research : MCR 20110701
Inhibitor of heat shock protein is a potential anticancer drug, Penn study finds. Cancer biology & therapy 20091101
A small molecule inhibitor of inducible heat shock protein 70. Molecular cell 20091009
Synthesis and structure-activity relationships in a series of ethenesulfonamide derivatives, a novel class of endothelin receptor antagonists. Chemical & pharmaceutical bulletin 20011201
Carbonic anhydrase inhibitors: allylsulfonamide, styrene sulfonamide, N-allyl sulfonamides and some of their Si, Ge, and B derivatives. Journal of enzyme inhibition 20011201
Ethenesulfonamide and ethanesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists. Bioorganic & medicinal chemistry 20011101
Ethenesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists. Chemical & pharmaceutical bulletin 20010501

Related Products

© 2019 Angene International Limited. All rights Reserved.